Thomas Kremer

Basel, BS 4070, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Defining the Cis-Regulatory Elements of SCN1A in GABAergic Interneurons.

Defining the Cis-Regulatory Elements of SCN1A in GABAergic Interneurons.

Journal: Molecular neurobiology
Published: April 23, 2025

Angelman syndrome patient-derived neuron screen leads to clinical ASO rugonersen targeting UBE3A-ATS with long-lasting effect in monkeys.

Angelman syndrome patient-derived neuron screen leads to clinical ASO rugonersen targeting UBE3A-ATS with long-lasting effect in monkeys.

Journal: Nucleic acids research
Published: February 10, 2025

UBE3A reinstatement restores behaviorand proteome in an Angelman syndrome mouse model of imprinting defects.

UBE3A reinstatement restores behaviorand proteome in an Angelman syndrome mouse model of imprinting defects.

Journal: Molecular autism
Published: December 19, 2024

Brain expression profiles of two SCN1A antisense RNAs in children and adolescents with epilepsy.

Brain expression profiles of two SCN1A antisense RNAs in children and adolescents with epilepsy.

Journal: Translational neuroscience
Published: September 29, 2023

Multi-platform quantitation of alpha-synuclein human brain proteoforms suggests disease-specific biochemical profiles of synucleinopathies.

Multi-platform quantitation of alpha-synuclein human brain proteoforms suggests disease-specific biochemical profiles of synucleinopathies.

Journal: Acta neuropathologica communications
Published: March 15, 2022

AntimiR targeting of microRNA-134 reduces seizures in a mouse model of Angelman syndrome.

AntimiR targeting of microRNA-134 reduces seizures in a mouse model of Angelman syndrome.

Journal: Molecular therapy. Nucleic acids
Published: August 17, 2021

A cross-species spatiotemporal proteomic analysis identifies UBE3A-dependent signaling pathways and targets.

A cross-species spatiotemporal proteomic analysis identifies UBE3A-dependent signaling pathways and targets.

Journal: Molecular psychiatry
Published: August 16, 2021

Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders.

Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders.

Journal: Movement disorders : official journal of the Movement Disorder Society
Published: March 31, 2021

The subcellular arrangement of alpha-synuclein proteoforms in the Parkinson's disease brain as revealed by multicolor STED microscopy.

The subcellular arrangement of alpha-synuclein proteoforms in the Parkinson's disease brain as revealed by multicolor STED microscopy.

Journal: Acta neuropathologica
Published: February 21, 2021

Antisense oligonucleotide treatment rescues UBE3A expression and multiple phenotypes of an Angelman syndrome mouse model.

Antisense oligonucleotide treatment rescues UBE3A expression and multiple phenotypes of an Angelman syndrome mouse model.

Journal: JCI insight
Published: November 14, 2020

Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease.

Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease.

Journal: Movement disorders : official journal of the Movement Disorder Society
Published: September 15, 2020

Immunohistochemical Detection of Synuclein Pathology in Skin in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinsonism.

Immunohistochemical Detection of Synuclein Pathology in Skin in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinsonism.

Journal: Movement disorders : official journal of the Movement Disorder Society
Published: August 05, 2020
Showing 1-12 of 23

Last Updated: 09/26/2026